Cubist Pharmaceuticals Issues Voluntary Nationwide Recall of One Lot of CUBICIN (daptomycin for injection) 500 mg in 10 mL single use vials Due to Presence of Particulate Matter

[Business Wire] – Cubist Pharmaceuticals, Inc. today announced it is voluntarily recalling one lot of CUBICIN® to the user level due to the presence of part more

View todays social media effects on CBST

View the latest stocks trending across Twitter. Click to view dashboard

See who Cubist is hiring next, click here to view